ReviewNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2026
The updated global burden of chronic kidney disease: one death every 20 seconds.
Review in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Facilitators and Barriers to Digital Health Technologies for Self-Management in Patients With Chronic Kidney Disease: Systematic Review Based on the Updated CFIR 2.0 Framework.Journal of medical Internet research · 2026Pooled it
- Impact of health education on quality of life in patients with chronic kidney disease.iScience · 2026Article
- Randomized Trial of Dietary Nitrate Supplementation in CKD Pregnancy (ORCHARD-BEET).Kidney international reports · 2026Article
- Review
- Implementation of a Laboratory-Integrated Clinical Decision Support System for CKD Screening and Progression Detection in Primary Care.Biomedicines · 2026Article
- Point-of-Care Assessment of Kidney Function in Chronic Kidney Disease: Current Technologies and Future Perspectives.Medical sciences (Basel, Switzerland) · 2026Review
- Research Progress and Critical Challenges of Bioartificial Kidneys in Renal Replacement Therapy for End-Stage Renal Disease.Biomolecules · 2026Review
- A deep learning model for opportunistic screening of chronic kidney disease using chest radiographs: a multicentre validation study in the USA.EClinicalMedicine · 2026Article
- Targeting Uremic Toxins in Chronic Kidney Disease: Current Challenges and Emerging Therapeutic Strategies.Toxins · 2026Review
- Abstract submissions to the ERA Congress: what they tell us about nephrology's trajectory.Clinical kidney journal · 2026Article
- Adaptive immune cells and kidney function in older adults: sex-specific associations in the health and retirement study (HRS).Frontiers in aging · 2026Article
- Association of Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio with Mortality in Patients on Maintenance Hemodialysis: A Retrospective Cohort Study.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In 2024, Global Burden of Disease (GBD) updated the forecast of global cause-specific age-standardized death rates. Chronic kidney disease (CKD) was forecast to increase by over 30% from 2022, while stroke and ischaemic heart disease would decrease by more than 40%. In western Europe, CKD would become the third cause of death by 2050. While proactive primary prevention has been key to addressing the burden of stroke and ischaemic heart disease, its role in CKD has been often neglected. In 2025, the World Health Organization and Kidney Disease: Improving Global Outcomes produced documents emphasizing maintenance of kidney health and GBD updated the global epidemiology estimates for CKD and kidney replacement therapy (KRT). The new data support the previous estimate that there are 850 million people with kidney disease globally, of whom 4.6 million are on KRT, and 1.5 million people annually (one every 20 seconds) die from CKD. In Europe, an estimated 93.1 million adults have CKD, of whom 750 000 are on KRT, and 210 000 people (one every 2.5 minutes) die from CKD. Of relevance for public health planning, diabetes and hypertension accounted for ≤30% of prevalent KRT in Europe. GBD estimates extend data currently available through the European Renal Association Registry by including additional countries where prevalence of KRT is high: Germany, for example, is home to over 77 000 people on KRT. Overall, these updated data confirm the severity of the global and European CKD burden and call for urgent action to develop novel strategies that expand beyond screening, early diagnosis and treatment of CKD to also encompass proactive primary prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.